991 related articles for article (PubMed ID: 16409995)
21. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
Comer SD; Burke TF; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
[TBL] [Abstract][Full Text] [Related]
22. Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.
Alonzo NC; Bayer BM
J Pharmacol Exp Ther; 2003 Nov; 307(2):793-800. PubMed ID: 12966157
[TBL] [Abstract][Full Text] [Related]
23. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone.
Crain SM; Shen KF
Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459
[TBL] [Abstract][Full Text] [Related]
24. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?
Rubovitch V; Pick CG; Sarne Y
Addict Biol; 2009 Sep; 14(4):438-46. PubMed ID: 19489750
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
Zhao M; Joo DT
Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
[TBL] [Abstract][Full Text] [Related]
26. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence.
Shen KF; Crain SM
Brain Res; 2001 Nov; 919(1):20-30. PubMed ID: 11689159
[TBL] [Abstract][Full Text] [Related]
27. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance.
Shavit Y; Wolf G; Goshen I; Livshits D; Yirmiya R
Pain; 2005 May; 115(1-2):50-9. PubMed ID: 15836969
[TBL] [Abstract][Full Text] [Related]
29. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia.
Crain SM; Shen KF
Brain Res; 2001 Jan; 888(1):75-82. PubMed ID: 11146054
[TBL] [Abstract][Full Text] [Related]
30. Role of mu-opioid and NMDA receptors in the development and maintenance of repeated swim stress-induced thermal hyperalgesia.
Suarez-Roca H; Silva JA; Arcaya JL; Quintero L; Maixner W; Pinerua-Shuhaibar L
Behav Brain Res; 2006 Feb; 167(2):205-11. PubMed ID: 16214233
[TBL] [Abstract][Full Text] [Related]
31. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
Tiseo PJ; Inturrisi CE
J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
[TBL] [Abstract][Full Text] [Related]
32. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
[TBL] [Abstract][Full Text] [Related]
33. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
Kolesnikov Y; Pasternak GW
J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
[TBL] [Abstract][Full Text] [Related]
34. Characterization of morphine-induced hyperalgesia in male and female rats.
Holtman JR; Wala EP
Pain; 2005 Mar; 114(1-2):62-70. PubMed ID: 15733632
[TBL] [Abstract][Full Text] [Related]
35. High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.
Shu H; Hayashida M; Arita H; Huang W; Xiao L; Chiba S; Sekiyama H; Hanaoka K
J Ethnopharmacol; 2008 Sep; 119(2):276-83. PubMed ID: 18687394
[TBL] [Abstract][Full Text] [Related]
36. Reversal of tolerance to the antitransit effects of morphine during acute intestinal inflammation in mice.
Pol O; Puig MM
Br J Pharmacol; 1997 Nov; 122(6):1216-22. PubMed ID: 9401789
[TBL] [Abstract][Full Text] [Related]
37. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
Schmidt AP; Tort AB; Silveira PP; Böhmer AE; Hansel G; Knorr L; Schallenberger C; Dalmaz C; Elisabetsky E; Crestana RH; Lara DR; Souza DO
Pharmacol Biochem Behav; 2009 Feb; 91(4):549-53. PubMed ID: 18854198
[TBL] [Abstract][Full Text] [Related]
38. Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
Rady JJ; Holmes BB; Tseng LF; Fujimoto JM
J Pharmacol Exp Ther; 2001 May; 297(2):582-9. PubMed ID: 11303046
[TBL] [Abstract][Full Text] [Related]
39. Opioid analgesia in the mouse: evidence for multiple receptors using beta-FNA.
Sánchez-Blázquez P; Garzón J
NIDA Res Monogr; 1986; 75():465-8. PubMed ID: 2828993
[TBL] [Abstract][Full Text] [Related]
40. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]